Christopher M. Bunce

Author

Also Known As

Bunce, C. M., Bunce, Christopher M., Bunce, Christopher Martin., C BUNCE, C Bunce, C M Bunce, C. Bunce, C. M. BUNCE, C. M. Bunce, C.M Bunce

169

Publications

4.6K

Citations

H-Index

115

Concepts

All Affiliations

University of Birmingham The Edgbaston Hospital

About

Christopher M. Bunce is an author at University of Birmingham specializing in medicine, cell biology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	39	2.3K
2	Health Sciences	10	10	862
3	Natural Sciences	7	7	293
4	Engineering	4	4	556
5	Management	1	1	187

Christopher M. Bunce

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors Charlotte Bradbury, Farhat L. Khanim, Rachel Hayden, Leukemia Histone ModificationsChromatinHistone DeacetylasesHematological MalignancyChromatin Remodeling	2005	395
Optimized metabolite extraction from blood serum for 1H nuclear magnetic resonance spectroscopy Stefano Tiziani, Abdul‐Hamid Emwas, Alessia Lodi, Analytical Biochemistry EngineeringMagnetic ResonanceMetabolomic ProfilingSpectrochemical AnalysisBioanalysis	2008	193
Assessment of the hazard from rock fall on a highway Christopher M. Bunce, D. M. Crudën, N. R. Morgenstern Canadian Geotechnical Journal Rock TestingEngineeringRock SlopeSafety ScienceInjury Prevention	1997	187
Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells Adamantios Serafeim, Michelle J. Holder, Gillian Grafton, Blood	2003	168
Characterization of Two Novel Aldo–Keto Reductases from Arabidopsis: Expression Patterns, Broad Substrate Specificity, and an Open Active-Site Structure Suggest a Role in Toxicant Metabolism Following Stress Paul J. Simpson, Chonticha Tantitadapitak, Anna M. Reed, Journal of Molecular Biology Broad Substrate SpecificityEngineeringBiochemistryAldo-keto ReductaseExpression Patterns	2009	162
The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs. Julian C. Desmond, Joanne C. Mountford, Mark T. Drayson, PubMed Chemoprevention StrategyCell DeathCell DifferentiationTumor BiologyOxidative Stress	2003	152
PEP005, a selective small-molecule activator of protein kinase C, has potent antileukemic activity mediated via the delta isoform of PKC Peter Hampson, Hema Chahal, Farhat L. Khanim, Blood	2005	131
Crystal Structures of Prostaglandin D2 11-Ketoreductase (AKR1C3) in Complex with the Nonsteroidal Anti-Inflammatory Drugs Flufenamic Acid and Indomethacin Andrew L. Lovering, Jon P. Ride, Christopher M. Bunce, Cancer Research	2004	118
Metabolomic Profiling of Drug Responses in Acute Myeloid Leukaemia Cell Lines Stefano Tiziani, Alessia Lodi, Farhat L. Khanim, PLoS ONE Mixed-phenotype Acute LeukemiaMetabolomic ProfilingMetabolic RemodelingOxidative StressMyeloid Neoplasia	2009	117
A quick, simple and unbiased method to quantify C2C12 myogenic differentiation Pedro Veliça, Christopher M. Bunce Muscle & Nerve	2011	104

Page 1